On January 23, 2026, Dare Bioscience, Inc. designated 4,999,620 shares of Series A Convertible Preferred Stock at an initial value of $5.00 per share, to be included in a new offering. The company also aims to conduct a Regulation A offering of up to 4,854,000 units, priced at $5.00 each, through which 5,090 shares and corresponding warrants were issued.